- Home
- VCV vs SRDX Comparison
VCV vs SRDX Comparison
Compare VCV & SRDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCV
- SRDX
- Stock Information
- Founded
- VCV 1993
- SRDX 1979
- Country
- VCV United States
- SRDX United States
- Employees
- VCV N/A
- SRDX N/A
- Industry
- VCV Trusts Except Educational Religious and Charitable
- SRDX Medical/Dental Instruments
- Sector
- VCV Finance
- SRDX Health Care
- Exchange
- VCV Nasdaq
- SRDX Nasdaq
- Market Cap
- VCV 501.9M
- SRDX 562.6M
- IPO Year
- VCV N/A
- SRDX 1998
- Fundamental
- Price
- VCV $11.11
- SRDX $33.97
- Analyst Decision
- VCV
- SRDX Hold
- Analyst Count
- VCV 0
- SRDX 4
- Target Price
- VCV N/A
- SRDX $43.00
- AVG Volume (30 Days)
- VCV 107.9K
- SRDX 347.5K
- Earning Date
- VCV 01-01-0001
- SRDX 01-30-2025
- Dividend Yield
- VCV 4.09%
- SRDX N/A
- EPS Growth
- VCV N/A
- SRDX N/A
- EPS
- VCV 0.13
- SRDX N/A
- Revenue
- VCV N/A
- SRDX $125,448,000.00
- Revenue This Year
- VCV N/A
- SRDX $13.75
- Revenue Next Year
- VCV N/A
- SRDX $13.67
- P/E Ratio
- VCV $75.82
- SRDX N/A
- Revenue Growth
- VCV N/A
- SRDX N/A
- 52 Week Low
- VCV $8.05
- SRDX $25.17
- 52 Week High
- VCV $10.40
- SRDX $42.44
- Technical
- Relative Strength Index (RSI)
- VCV 65.47
- SRDX 25.93
- Support Level
- VCV $10.70
- SRDX $36.23
- Resistance Level
- VCV $11.01
- SRDX $36.21
- Average True Range (ATR)
- VCV 0.11
- SRDX 1.17
- MACD
- VCV 0.01
- SRDX -0.32
- Stochastic Oscillator
- VCV 98.02
- SRDX 8.64
About VCV Invesco California Value Municipal Income Trust
Invesco California Value Municipal Income Trust is engaged in the field of financial services. Its objective is to seek to provide common shareholders with a high level of current income exempt from federal and California income taxes, consistent with preservation of capital.
About SRDX Surmodics Inc.
Surmodics Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The company's mission is to improve the treatment and detection of disease by using its technology to provide solutions to difficult medical devices and diagnostic challenges. It has two reportable segments: Medical device unit; Manufacture of performance coatings, including surface modification coating technologies and the Vitro diagnostics unit; Manufacture of chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets. Surmodics derives majority of its revenue from the Medical Device segment.